Medical Properties Trust, Inc. (NYSE:MPW)‘s stock had its “buy” rating restated by analysts at SunTrust Banks, Inc. in a research note issued to investors on Friday. They currently have a $15.00 target price on the real estate investment trust’s stock. SunTrust Banks, Inc.’s target price points to a potential upside of 10.38% from the company’s current price. SunTrust Banks also issued estimates for Medical Properties Trust’s FY2017 earnings at $1.32 EPS and Q3 2018 earnings at $0.37 EPS.

Several other research analysts also recently weighed in on MPW. BidaskClub downgraded shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. JMP Securities upgraded shares of Medical Properties Trust from a “market perform” rating to an “outperform” rating and set a $14.00 price target on the stock in a research report on Monday, July 17th. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 price target on the stock in a research report on Wednesday, July 19th. Royal Bank Of Canada reiterated a “buy” rating and issued a $16.00 price target on shares of Medical Properties Trust in a research report on Monday, July 24th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $13.00 price target on shares of Medical Properties Trust in a research report on Friday, July 28th. Two analysts have rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $14.18.

Medical Properties Trust (NYSE MPW) opened at $13.59 on Friday. Medical Properties Trust has a one year low of $11.54 and a one year high of $14.22. The company has a current ratio of 2.55, a quick ratio of 2.06 and a debt-to-equity ratio of 1.26. The firm has a market cap of $4.95 billion, a P/E ratio of 10.43, a price-to-earnings-growth ratio of 2.00 and a beta of 0.95.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 EPS for the quarter, beating the Zacks’ consensus estimate of $0.32 by $0.01. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The firm had revenue of $176.60 million for the quarter, compared to analysts’ expectations of $172.57 million. During the same quarter in the prior year, the company posted $0.30 earnings per share. The business’s revenue for the quarter was up 39.5% on a year-over-year basis. equities research analysts expect that Medical Properties Trust will post 1.31 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Medical Properties Trust, Inc. (MPW) Earns Buy Rating from SunTrust Banks, Inc.” was originally reported by American Banking News and is owned by of American Banking News. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/11/04/medical-properties-trust-inc-mpw-earns-buy-rating-from-suntrust-banks-inc.html.

Several hedge funds have recently added to or reduced their stakes in MPW. BlackRock Japan Co. Ltd raised its holdings in shares of Medical Properties Trust by 0.5% in the 1st quarter. BlackRock Japan Co. Ltd now owns 12,577 shares of the real estate investment trust’s stock valued at $163,000 after purchasing an additional 65 shares in the last quarter. Daiwa Securities Group Inc. raised its holdings in shares of Medical Properties Trust by 1.2% in the 2nd quarter. Daiwa Securities Group Inc. now owns 8,500 shares of the real estate investment trust’s stock valued at $129,000 after purchasing an additional 100 shares in the last quarter. BB&T Securities LLC raised its holdings in shares of Medical Properties Trust by 0.3% in the 2nd quarter. BB&T Securities LLC now owns 31,541 shares of the real estate investment trust’s stock valued at $405,000 after purchasing an additional 102 shares in the last quarter. MCF Advisors LLC raised its holdings in shares of Medical Properties Trust by 1.5% in the 3rd quarter. MCF Advisors LLC now owns 8,526 shares of the real estate investment trust’s stock valued at $126,000 after purchasing an additional 129 shares in the last quarter. Finally, Integrated Investment Consultants LLC raised its holdings in shares of Medical Properties Trust by 1.4% in the 3rd quarter. Integrated Investment Consultants LLC now owns 9,554 shares of the real estate investment trust’s stock valued at $139,000 after purchasing an additional 130 shares in the last quarter. 84.05% of the stock is owned by hedge funds and other institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.